JNJ-28431754

· Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for JNJ-28431754, covering 2010-08-11 to 2014-04-23. Get the full timeline:

Most recent: Clinical Trial Update: A Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics Study of JNJ-28431754 in Patients With Type 2 Diabetes Mellitus [Phase 1]

See pricing